Sickle Cell
Protocol:GBT440-031
Condition or Disease: Sickle Cell Disease
Study Type: Interventional (Clinical Trial)
Status: Enrollment Paused
Study Title: A Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Subjects with Sickle Cell Disease
Principal I investigator: Alan Ikeda, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03036813
Cure 4 The Kids Foundation (C4K) is pleased to announce the addition of Dr. Suraj Pratap, M.D. to their team of healthcare providers. Dr. Pratap brings with him a wealth of experience, having previously practiced general pediatrics in Las Vegas. He recently obtained his board-certification in pediatric hematology oncology, which will provide additional resources and expertise to C4K’s existing team of seven providers. Fluent in both English and Hindi, Dr. Pratap is now seeing C4K patients.
Christmas 4 The Kids Digital Album Benefits Pediatric Patients at Cure 4 The Kids Foundation
